© Globe Newswire
22.08.2024
BAVA
LISTED
CPH
Bavarian Nordic Announces First Half 2024 Results
News Preview
COPENHAGEN, Denmark, August 22, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2024 and released its financial calendar for 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.08.2024
GN
LISTED
CPH
Interim Report Q2 2024: Strong execution leading to 5% organic growth and margin expansion
News Preview
Highlights...
Themefolio
Profiler
Peergroup
© BusinessWire
21.08.2024
EHAB
LISTED
NYSE
Enhabit Announces Participation in Upcoming Investor Conferences
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced its participation in two upcoming investor conferences.
Enhabit’s President and Chief Executive Officer Barb Jacobsmeyer and Chief Financial Officer Crissy Carlisle will participate in the following events:
Jefferies Healthcare Services “Back to School” Su...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
21.08.2024
BAVA
LISTED
CPH
Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country
News Preview
COPENHAGEN, Denmark, August 21, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract of 440,000 doses to supply its MVA-BN® smallpox/mpox vaccine to an undisclosed European country....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
21.08.2024
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Niclas Lindstedt
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 21 AUGUST 2024 at 18.45 EEST ...
Themefolio
Profiler
Peergroup
© PR Newswire
21.08.2024
RAY B
LISTED
STO
Connecticut Proton Therapy Center selects RayCare
News Preview
STOCKHOLM, Aug. 21, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that the Connecticut Proton Therapy Center, Wallingford, Connecticut, USA, has placed an order for the oncology information system RayCare®*.
The Connecticut Proton Therapy Center will be the first of its kind in the state of Connecticut and is a col...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2024
HIK
LISTED
LSE
Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention Day
News Preview
LONDON, Aug. 20, 2024 /PRNewswire/ -- Hikma Pharmaceuticals in the US joined government officials and non-profit leaders today at a naloxone awareness and training event organized and hosted by Rep. Earl L. "Buddy" Carter of Georgia. This important educational event took place at Groves High School in Savannah, Ga. ahead of National Fentanyl Awar...
Themefolio
Profiler
Peergroup
© EQS Newswire
20.08.2024
EUZ
LISTED
XETR
Eckert & Ziegler eröffnet neue Betriebsgebäude für radiopharmazeutischen Anlagenbau in Dresden
News Preview
Berlin, 20.08.2024. In Anwesenheit der sächsischen Staatsminister Martin Dulig und Thomas Schmidt sowie des Dresdner Oberbürgermeisters Dirk Hilbert hat das Medizintechnikunternehmen Eckert & Ziegler heute mit rund 200 Gästen seine neuen, 1.700 qm großen Betriebsgebäude in Dresden eingeweiht. Am Standort Dresden-Rossendorf werden hoch technolog......
Themefolio
Profiler
Peergroup
© EQS Newswire
20.08.2024
EUZ
LISTED
XETR
Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden
News Preview
Berlin, 20.08.2024. In the presence of the Saxon State Ministers Martin Dulig and Thomas Schmidt as well as the Mayor of Dresden Dirk Hilbert, the medical technology company Eckert & Ziegler today inaugurated its new 1,700 square meter facilities in Dresden with around 200 guests. The Dresden-Rossendorf site produces and delivers high-tech syst......
Themefolio
Profiler
Peergroup
© EQS Newswire
20.08.2024
VLA
LISTED
EURONEXT
First Berlin Equity Research GmbH: Valneva SE | Rating: Buy
News Preview
Original-Research: Valneva SE - from First Berlin Equity Research GmbH
20.08.2024 / 16:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude cert......
Themefolio
Profiler
Peergroup
© BusinessWire
20.08.2024
AMRX
LISTED
NASDAQ
Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (“ANDA”) approval from the U.S. Food and Drug Administration (FDA) for Propofol Injectable Emulsion USP, 200 mg/20 mL (10 mg/mL), 500 mg/50 mL (10 mg/mL), and 1,000 mg/100 mL (10 mg/mL), Single-Dose Vials....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2024
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Liisa Hurme
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 20 AUGUST 2024 at 16.15 EEST ...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
20.08.2024
LEGN
LISTED
NASDAQ
Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
News Preview
SOMERSET, N.J., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on Wednesda...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2024
COLO B
LISTED
CPH
Coloplast A/S - Interim Financial Report, 9M 2023/24
News Preview
9M 2023/24Interim financial results, 9M 2023/241 October 2023 - 30 June 2024...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2024
INDV
LISTED
NASDAQ
INDV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Indivior PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
News Preview
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Indivior PLC (“Indivior” or “the Company”) (NASDAQ: INDV) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged violat...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2024
GMAB
LISTED
CPH
TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2024
LIVN
LISTED
NASDAQ
LivaNova to Present at the Baird Global Healthcare Conference
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Baird 2024 Global Healthcare Conference in New York. The presentation will take place at 10:15 a.m. Eastern Time on Tuesday, September 10.
The discussion will be available...
Themefolio
Profiler
Peergroup
© EQS Newswire
19.08.2024
FYB
LISTED
XETR
First Berlin Equity Research GmbH: Formycon AG | Rating: Buy
News Preview
Original-Research: Formycon AG - from First Berlin Equity Research GmbH
19.08.2024 / 14:10 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude cer......
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2024
BIOA B
LISTED
STO
Invitation to presentation of BioArctic's second quarter report for April - June 2024 on August 29 at 9.30 a.m. CET
News Preview
STOCKHOLM, Aug. 19, 2024 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) will publish the company's second quarter report for April - June 2024 on Thursday, August 29, 2024, at 08:00 a.m. CET.
In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on August 2...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2024
BIOA B
LISTED
STO
Invitation to presentation of BioArctic's second quarter report for April - June 2024 on August 29 at 9.30 a.m. CET
News Preview
STOCKHOLM, Aug. 19, 2024 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) will publish the company's second quarter report for April - June 2024 on Thursday, August 29, 2024, at 08:00 a.m. CET.
In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on August 2...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.08.2024
BAVA
LISTED
CPH
Bavarian Nordic Provides Statement on Mpox Vaccine Supply and Collaboration with African and Global Stakeholders
News Preview
COPENHAGEN, Denmark, August 17, 2024 – Bavarian Nordic A/S (OMX: BAVA) provides an update on plans for securing supply of vaccines to tackle the current mpox outbreak that the Africa Centers for Disease Control and Prevention (Africa CDC) declared as a Public Health Emergency of Continental Security (PHECS) on August 13, 2024 followed by the World...
Themefolio
Profiler
Peergroup
© BusinessWire
16.08.2024
SKYE
LISTED
NASDAQ
Skye Bioscience, Inc. (SKYE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
News Preview
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Skye Bioscience, Inc. (“Skye” or “the Company”) (NASDAQ: SKYE). Investors who purchased Skye securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SKYE....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.08.2024
ZEAL
LISTED
CPH
Zealand Pharma major shareholder announcement: Bank of America Corporation
News Preview
Company announcement – No. 40 / 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.08.2024
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Please see the full announcement in PDF ...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.08.2024
GMAB
LISTED
CPH
Genmab Announces Changes to its Executive Committee
News Preview
Media Release...
Themefolio
Profiler
Peergroup
© PR Newswire
16.08.2024
RAY B
LISTED
STO
RaySearch Laboratories: Interim report April - June 2024
News Preview
STOCKHOLM, Aug. 16, 2024 /PRNewswire/ --
SECOND QUARTER (APRIL- JUNE 2024)
Order intake SEK 290.3 M (239.2)Net sales SEK 318.9 M (239.5)Operating profit SEK 79.3 M (18.2)Profit after tax SEK 61.4 M (10.9)Earnings per share before/after dilution SEK 1.79 (0.32)Cash flow from operating activities SEK 154.6 M (67.2)Order backlog SEK 1,790.5...
Themefolio
Profiler
Peergroup
© PR Newswire
15.08.2024
HIK
LISTED
LSE
KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 months
News Preview
LONDON, Aug. 15, 2024 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the shelf-life extension of KLOXXADO® (naloxone HCl) nasal spray 8mg from 24 to 36 months. KLOXXADO® packaging has been updated with 36-month dating, starting with product manufactured in March 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.08.2024
TRAW
LISTED
NASDAQ
Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights
News Preview
Merger with Trawsfynydd Therapeutics, Inc (“Trawsfynydd”) and concurrent private placement of $14 million (cash runway to support planned operations through year end), with recently achieved clinical milestones, put Traws on track to achieve key readouts for the clinical pipeline in H2 2024 and beyond...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.08.2024
ZEAL
LISTED
CPH
Zealand Pharma Announces Financial Results for the First Half of 2024
News Preview
Company announcement - No. 39 / 2024...
Themefolio
Profiler
Peergroup
© BusinessWire
14.08.2024
ICLR
LISTED
NASDAQ
ICON Announces Appointment of New Chief Financial Officer
News Preview
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Nigel Clerkin as its new Chief Financial Officer (CFO).
Nigel brings extensive experience and capability to the role of CFO. He commenced his career with KPMG, before joining Elan Corporation where he held a num...
Themefolio
Profiler
Peergroup
© EQS Newswire
14.08.2024
ILM1
LISTED
XETR
Annual General Meeting resolves to expand the Supervisory Board to five members
News Preview
Press release
Medios AG: Annual General Meeting resolves to expand the Supervisory Board to five members
Berlin, August 14, 2024 – The shareholders of Medios, a leading provider of Specialty Pharma in Europe, today approved all but two of the resolutions proposed by the Executive Board and Supervisory Board at the Annual General Meeting. A total ......
Themefolio
Profiler
Peergroup
© EQS Newswire
14.08.2024
ILM1
LISTED
XETR
Hauptversammlung beschließt Erweiterung des Aufsichtsrats auf fünf Mitglieder
News Preview
Pressemitteilung
Medios AG: Hauptversammlung beschließt Erweiterung des Aufsichtsrats auf fünf Mitglieder
Berlin, 14. August 2024 – Die Aktionäre von Medios, ein führender Anbieter von Specialty Pharma in Europa, haben heute auf der ordentlichen Hauptversammlung allen Beschlussvorschlägen von Vorstand und Aufsichtsrat bis auf zwei Ausnahmen zuge......
Themefolio
Profiler
Peergroup
© BusinessWire
14.08.2024
BLUE
LISTED
NASDAQ
bluebird bio Reports Second Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
News Preview
bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported second quarter results and business highlights for the quarter ended June 30, 2024, including recent commercial and operational progress.
“We are seeing clear evidence that our commercial launch is accelerating, with over 20 cell collections completed in sickle ce...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.08.2024
POAI
LISTED
NASDAQ
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
News Preview
Company to host investor call and webcast today, August 14th, at 8:30am EDT Company to host investor call and webcast today, August 14th, at 8:30am EDT...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.08.2024
ANAB
LISTED
NASDAQ
Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
News Preview
Led by long-standing investor EcoR1 Capital with participation from additional existing and new investors, including Sanofi Led by long-standing investor EcoR1 Capital with participation from additional existing and new investors, including Sanofi...
Themefolio
Profiler
Peergroup
© EQS Newswire
14.08.2024
EVT
LISTED
XETR
Challenging year; priority reset for sustainable profitable growth gaining momentum, building on core strengths
News Preview
Softness in market for Shared R&D Services, with H1 2024 revenues down 7% year-on-year. Continued growth of sales order book in Discovery – higher share of integrated long-term deals will improve revenue contribution beyond 2024
Strong progress of Just – Evotec Biologics with H1 2024 revenues increase of 50% year-on-year; capacity r......
Themefolio
Profiler
Peergroup
© EQS Newswire
14.08.2024
EVT
LISTED
XETR
Herausforderndes Jahr; Neuausrichtung für nachhaltiges profitables Wachstum aufbauend auf Kernkompetenzen gewinnt an Dynamik
News Preview
Weicher Markt für Shared R&D Dienstleistungen; Umsatz geht im ersten Halbjahr 2024 im Vergleich zum Vorjahr um 7 % zurück. Anhaltendes Wachstum des Auftragsbestands im Bereich Discovery – höherer Anteil integrierter langfristiger Verträge wird Umsatzbeitrag über 2024 hinaus verbessern
Starker Fortschritt von Just – Evotec Biologics ......
Themefolio
Profiler
Peergroup
© Globe Newswire
14.08.2024
ORNBV
LISTED
HEL
44,767 Orion Corporation A shares converted into B shares
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE14 AUGUST 2024 at 9.30 EEST ...
Themefolio
Profiler
Peergroup
© PR Newswire
14.08.2024
BIOA B
LISTED
STO
Leqembi approved for the treatment of Alzheimer's disease in the United Arab Emirates
News Preview
STOCKHOLM, Aug. 14, 2024 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved Leqembi® (lecanemab) for the treatment of Alzheimer's disease (AD). Treatment with Leqembi should be initiated in patients with mild cogni...
Themefolio
Profiler
Peergroup
© PR Newswire
14.08.2024
BIOA B
LISTED
STO
Leqembi approved for the treatment of Alzheimer's disease in the United Arab Emirates
News Preview
STOCKHOLM, Aug. 13, 2024 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved Leqembi® (lecanemab) for the treatment of Alzheimer's disease (AD). Treatment with Leqembi should be initiated in patients with mild cogni...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.08.2024
TIL
LISTED
NASDAQ
Instil Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update
News Preview
DALLAS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its second quarter 2024 financial results and provided a corporate update....
Themefolio
Profiler
Peergroup
© Globe Newswire
13.08.2024
BAVA
LISTED
CPH
Bavarian Nordic Receives Order from HERA and Announces Significant Donation of Vaccines in Response to the Mpox Outbreak in Africa
News Preview
COPENHAGEN, Denmark, August 13, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today a new order from HERA (the European Health Emergency Preparedness and Response Authority) for the Company’s MVA-BN® vaccine, the only FDA and EMA-approved mpox vaccine. HERA will procure 175,420 doses of the vaccine for donation to the Africa CDC (Centres for Dis...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.08.2024
GMAB
LISTED
CPH
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.08.2024
GMAB
LISTED
CPH
Capital Increase in Genmab as a Result of Employee Warrant Exercise
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© BusinessWire
13.08.2024
INDV
LISTED
NASDAQ
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Indivior PLC (INDV)
News Preview
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 1, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Indivior PLC (“Indivior” or the “Company”) (NASDAQ: INDV) securities between February 22, 2024 and July 8, 2024, inclusive (the “Clas...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.08.2024
BAVA
LISTED
CPH
Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine
News Preview
COPENHAGEN, Denmark, August 13, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the Biologics License Application (BLA) for CHIKV VLP, the Company’s vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in indiv...
Themefolio
Profiler
Peergroup
© BusinessWire
13.08.2024
HELP
LISTED
NASDAQ
Cybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive Disorder
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced that it held a Type B Initial Breakthrough Therapy Meeting with the U.S. Food and Drug Ad...
Themefolio
Profiler
Peergroup
© BusinessWire
13.08.2024
DFTX
LISTED
NASDAQ
MindMed Reports Second Quarter 2024 Financial Results and Business Updates
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced its financial results for the quarter ended June 30, 2024, and provided a business update.
“Building on the positive momentum from our Phase 2b...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.08.2024
MURA
LISTED
NASDAQ
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
News Preview
Company remains well positioned to capitalize on the role of cytokines with near- and long-term potential value creation milestones, reiterates guidance on projected cash runway into Q4 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.08.2024
ATAI
LISTED
NASDAQ
atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
News Preview
atai Reports Q2 2024 Financial Results and Corporate Updates...
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2024
EUZ
LISTED
XETR
Eckert & Ziegler wird europäischer Lohnhersteller für innovative ProstACT GLOBAL Phase III-Studie von Telix
News Preview
Berlin, 13. August 2024 - Eckert & Ziegler und Telix Pharmaceuticals Limited (Telix) gaben heute die Unterzeichnung eines bedeutenden Mehrjahresvertrages bekannt, in dessen Rahmen Eckert & Ziegler als europäischer Auftragshersteller (CMO) für Telix' ProstACT GLOBAL Phase III Studie fungieren wird. Die Vereinbarung umfasst die Versorgung der......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2024
EUZ
LISTED
XETR
Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
News Preview
Berlin, August 13, 2024 - Eckert & Ziegler and Telix Pharmaceuticals Limited (Telix) today announced the signing of a significant multi-year agreement under which Eckert & Ziegler will serve as the European contract manufacturing organization (CMO) for Telix's ProstACT GLOBAL Phase III study. The contract covers the supply of the entire Eur......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2024
ILM1
LISTED
XETR
Medios AG continues its growth trajectory in the first half of 2024 and records disproportionately high increase in earnings
News Preview
Press release
Medios AG continues its growth trajectory in the first half of 2024 and records disproportionately high increase in earnings
Revenue increases by 6.3% and EBITDA pre1 by 7.3% in the first half of the year
Cash flow from operating activities increases significantly to €34.0 million
Acquisition of Ceban successfully completed in Jun......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2024
ILM1
LISTED
XETR
Medios AG setzt Wachstumskurs im ersten Halbjahr 2024 fort und verzeichnet überproportionale Ergebnissteigerung
News Preview
Pressemitteilung
Medios AG setzt Wachstumskurs im ersten Halbjahr 2024 fort und verzeichnet überproportionale Ergebnissteigerung
Umsatz steigt im ersten Halbjahr um 6,3 % und EBITDA pre1 um 7,3 %
Cashflow aus betrieblicher Tätigkeit erhöht sich deutlich auf 34,0 Mio. €
Übernahme von Ceban im Juni 2024 erfolgreich abgeschlossen
Ausblick 2024 be......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2024
EVT
LISTED
XETR
Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb
News Preview
Key scientific achievements drive the expansion of the pipeline of molecular glue degraders
Performance-based and programme-based payments of in total US$ 75 m to Evotec
Hamburg, Germany, 13 August 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced further strong progr......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2024
EVT
LISTED
XETR
Evotec verkündet starke Fortschritte in strategischer Partnerschaft mit Bristol Myers Squibb im Bereich Protein Degradation
News Preview
Wichtige wissenschaftliche Erfolge treiben die Erweiterung der Pipeline von Molecular Glue Degraders voran
Leistungs- und programmabhängige Zahlungen an Evotec in Höhe von insgesamt 75 Mio. US$
Hamburg, 13. August 2024:
Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute weitere......
Themefolio
Profiler
Peergroup
© PR Newswire
13.08.2024
CALTX
LISTED
STO
Calliditas Interim Report January to June 2024
News Preview
STOCKHOLM, Aug. 13, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (STO: CALTX) :
April to June 2024 (compared to April to June 2023)
Net sales amounted to SEK 559.8 million, of which TARPEYO® net sales amounted to SEK 493.4 million, for the three months ended June 30, 2024. For the three months ended June 30, 2023, net sales amo...
Themefolio
Profiler
Peergroup
© PR Newswire
13.08.2024
CALTX
LISTED
STO
Calliditas Interim Report January to June 2024
News Preview
STOCKHOLM, Aug. 13, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (STO: CALTX) :
April to June 2024 (compared to April to June 2023)
Net sales amounted to SEK 559.8 million, of which TARPEYO® net sales amounted to SEK 493.4 million, for the three months ended June 30, 2024. For the three months ended June 30, 2023, net sales amo...
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2024
FYB
LISTED
XETR
Formycon reports a strong first half-year with multiple milestones achieved
News Preview
Press Release // August 13, 2024
Formycon reports a strong first half-year with multiple milestones achieved
Successful business development characterized by key operational, clinical, and regulatory milestones
Group revenue and EBITDA in line with expectations
Operating results of FYB201 in the first half of the year significantly exceeded ex......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.08.2024
FYB
LISTED
XETR
Formycon berichtet über starkes erstes Halbjahr mit zahlreichen Meilensteinen
News Preview
Pressemitteilung // 13. August 2024
Formycon berichtet über starkes erstes Halbjahr mit zahlreichen Meilensteinen
Erfolgreiche Geschäftsentwicklung geprägt durch wegweisende operative, klinische und regulatorische Meilensteine
Konzernumsatz und Konzern-EBITDA entsprechen Erwartungen
Operatives Ergebnis von FYB201 entwickelt sich im ersten Halb......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
